{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T12:08:46Z","timestamp":1779538126826,"version":"3.53.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,23]]},"DOI":"10.7759\/cureus.109484","type":"journal-article","created":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T11:57:33Z","timestamp":1779537453000},"source":"Crossref","is-referenced-by-count":0,"title":["The Silent Infection: Cytokine Blockade, Blunted Sepsis Physiology, and Soft Tissue Infection With NLRP12-Associated Autoinflammatory Syndrome"],"prefix":"10.7759","author":[{"given":"Alireza","family":"Izadian Bidgoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Gomez Veliz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-022-00669-8","article-title":"NLRP12-associated systemic autoinflammatory diseases in children","volume":"20","author":"Wang HF","year":"2022","unstructured":"Wang HF. NLRP12-associated systemic autoinflammatory diseases in children. Pediatr Rheumatol Online J. 2022, 20:9. 10.1186\/s12969-022-00669-8","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0708616105","article-title":"Mutations in NALP12 cause hereditary periodic fever syndromes","volume":"105","author":"J\u00e9ru I","year":"2008","unstructured":"J\u00e9ru I, Duquesnoy P, Fernandes-Alnemri T, et al.. Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci U S A. 2008, 105:1614-9. 10.1073\/pnas.0708616105","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2020.08.017","article-title":"Monogenic autoinflammatory disorders: conceptual overview, phenotype, and clinical approach","volume":"146","author":"Nigrovic PA","year":"2020","unstructured":"Nigrovic PA, Lee PY, Hoffman HM. Monogenic autoinflammatory disorders: conceptual overview, phenotype, and clinical approach. J Allergy Clin Immunol. 2020, 146:925-37. 10.1016\/j.jaci.2020.08.017","journal-title":"J Allergy Clin Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00652-9","article-title":"Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases","volume":"17","author":"Szekanecz Z","year":"2021","unstructured":"Szekanecz Z, McInnes IB, Schett G, Szamosi S, Benk\u0151 S, Sz\u0171cs G. Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nat Rev Rheumatol. 2021, 17:585-95. 10.1038\/s41584-021-00652-9","journal-title":"Nat Rev Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer M","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, et al.. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016, 315:801-10. 10.1001\/jama.2016.0287","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa304","article-title":"NLRP12 gene mutations and auto-inflammatory diseases: ever-changing evidence","volume":"59","author":"Del Porto F","year":"2020","unstructured":"Del Porto F, Cifani N, Proietta M, Verrecchia E, Di Rosa R, Manna R, Chiurazzi P. NLRP12 gene mutations and auto-inflammatory diseases: ever-changing evidence. Rheumatology (Oxford). 2020, 59:3129-36. 10.1093\/rheumatology\/keaa304","journal-title":"Rheumatology (Oxford)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/kzggp3","article-title":"NLRP12-associated autoinflammatory disease: much more than the FCAS phenotype","volume":"41","author":"Demir F","year":"2023","unstructured":"Demir F, S\u00f6zeri B. NLRP12-associated autoinflammatory disease: much more than the FCAS phenotype. Clin Exp Rheumatol. 2023, 41:2115-21. 10.55563\/clinexprheumatol\/kzggp3","journal-title":"Clin Exp Rheumatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-13-S1-P3","article-title":"Long-term safety and efficacy of Canakinumab in cryopyrin-associated periodic syndrome (CAPS) patients: results from beta-confident registry","volume":"13","author":"Kuemmerle-Deschner J","year":"2015","unstructured":"Kuemmerle-Deschner J, Hoffman H, Hawkins PN, van der Poll T, Walker UA, Speziale A, Tilson HH. Long-term safety and efficacy of Canakinumab in cryopyrin-associated periodic syndrome (CAPS) patients: results from beta-confident registry. Pediatr Rheumatol Online J. 2015, 13:P3. 10.1186\/1546-0096-13-S1-P3","journal-title":"Pediatr Rheumatol Online J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez270","article-title":"Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent fevers","volume":"59","author":"Papa R","year":"2020","unstructured":"Papa R, Rusmini M, Volpi S, et al.. Next generation sequencing panel in undifferentiated autoinflammatory diseases identifies patients with colchicine-responder recurrent fevers. Rheumatology (Oxford). 2020, 59:344-60. 10.1093\/rheumatology\/kez270","journal-title":"Rheumatology (Oxford)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40272-017-0232-6","article-title":"Monogenic periodic fever syndromes: treatment options for the pediatric patient","volume":"19","author":"Ozen S","year":"2017","unstructured":"Ozen S, Demir S. Monogenic periodic fever syndromes: treatment options for the pediatric patient. Paediatr Drugs. 2017, 19:303-11. 10.1007\/s40272-017-0232-6","journal-title":"Paediatr Drugs"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(20)30096-5","article-title":"Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome","volume":"2","author":"Mehta P","year":"2020","unstructured":"Mehta P, Cron RQ, Hartwell J, Manson JJ, Tattersall RS. Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome. Lancet Rheumatol. 2020, 2:e358-67. 10.1016\/S2665-9913(20)30096-5","journal-title":"Lancet Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206580","article-title":"Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers","volume":"74","author":"Federici S","year":"2015","unstructured":"Federici S, Sormani MP, Ozen S, et al.. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis. 2015, 74:799-805. 10.1136\/annrheumdis-2014-206580","journal-title":"Ann Rheum Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/art.41285","article-title":"On the alert for cytokine storm: immunopathology in COVID-19","volume":"72","author":"Henderson LA","year":"2020","unstructured":"Henderson LA, Canna SW, Schulert GS, et al.. On the alert for cytokine storm: immunopathology in COVID-19. Arthritis Rheumatol. 2020, 72:1059-63. 10.1002\/art.41285","journal-title":"Arthritis Rheumatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207546","article-title":"Recommendations for the management of autoinflammatory diseases","volume":"74","author":"ter Haar NM","year":"2015","unstructured":"ter Haar NM, Oswald M, Jeyaratnam J, et al.. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis. 2015, 74:1636-44. 10.1136\/annrheumdis-2015-207546","journal-title":"Ann Rheum Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/495500-the-silent-infection-cytokine-blockade-blunted-sepsis-physiology-and-soft-tissue-infection-with-nlrp12-associated-autoinflammatory-syndrome","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T11:57:33Z","timestamp":1779537453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/495500-the-silent-infection-cytokine-blockade-blunted-sepsis-physiology-and-soft-tissue-infection-with-nlrp12-associated-autoinflammatory-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,23]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.109484","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,23]]}}}